BC
Broadfin Capital Portfolio holdings
AUM
$403M
This Quarter Return
+9.76%
1 Year Return
+74.97%
3 Year Return
+245.63%
5 Year Return
+336.04%
10 Year Return
–
AUM
$634M
AUM Growth
+$634M
(+4.5%)
Cap. Flow
-$31.8M
Cap. Flow
% of AUM
-5.02%
Top 10 Holdings %
Top 10 Hldgs %
52.68%
Holding
60
New
15
Increased
10
Reduced
19
Closed
10
Top Buys
| 1 |
ADMS
Adamas Pharmaceuticals, Inc.
ADMS
|
$27.1M |
| 2 |
LJPC
La Jolla Pharmaceutical Company
LJPC
|
$18.7M |
| 3 |
AMAG
AMAG Pharmaceuticals, Inc.
AMAG
|
$12.1M |
| 4 |
KALA BIO
KALA
|
$10.8M |
| 5 |
NUVA
NuVasive, Inc.
NUVA
|
$9.2M |
Top Sells
| 1 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$30.8M |
| 2 |
RXDX
Ignyta, Inc.
RXDX
|
$30.7M |
| 3 |
Iovance Biotherapeutics
IOVA
|
$24.1M |
| 4 |
ENDP
Endo International plc
ENDP
|
$18.9M |
| 5 |
AngioDynamics
ANGO
|
$14.2M |
Sector Composition
| 1 | Healthcare | 88.23% |